Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Accounts Payables: 2015-2025

Historic Accounts Payables for Assembly Biosciences (ASMB) over the last 11 years, with Sep 2025 value amounting to $1.7 million.

  • Assembly Biosciences' Accounts Payables rose 26.07% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 26.07%. This contributed to the annual value of $585,000 for FY2024, which is 26.90% up from last year.
  • Per Assembly Biosciences' latest filing, its Accounts Payables stood at $1.7 million for Q3 2025, which was up 126.51% from $743,000 recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Accounts Payables registered a high of $3.6 million during Q1 2021, and its lowest value of $461,000 during Q4 2023.
  • Its 3-year average for Accounts Payables is $917,818, with a median of $801,000 in 2024.
  • Its Accounts Payables has fluctuated over the past 5 years, first tumbled by 81.51% in 2023, then skyrocketed by 76.12% in 2024.
  • Quarterly analysis of 5 years shows Assembly Biosciences' Accounts Payables stood at $2.7 million in 2021, then decreased by 6.24% to $2.5 million in 2022, then slumped by 81.51% to $461,000 in 2023, then increased by 26.90% to $585,000 in 2024, then climbed by 26.07% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $743,000 for Q2 2025, and $875,000 during Q1 2025.